BRAINS BIOCEUTICAL INITIATES CLINICAL TRIAL AGREEMENT TO TACKLE OPIOID ADDICTION

Corporate Breaking News

Home : BRAINS BIOCEUTICAL INITIATES CLINICAL TRIAL AGREEMENT TO TACKLE OPIOID ADDICTION

Feb 09 2022	BRAINS BIOCEUTICAL INITIATES CLINICAL TRIAL AGREEMENT TO TACKLE OPIOID ADDICTION
The approved investigational new drug (IND) study is for a PK study to use as a precursor in an Opiate addiction study VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ - Brains Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in pharmaceutical EU-GMP grade Cannabidiol (CBD)...


Source:https://www.prnewswire.com:443/news-releases/brains-bioceutical-initiates-clinical-trial-agreement-to-tackle-opioid-addiction-301478375.html

Related News
» La plateforme roumaine de cryptomonnaie Tradesilvania.com nomme Mihaela Drăgoiu, ancienne responsable de la direction de la supervision et du contrôle de l'unité d'intelligence financière (FIU) en Roumanie (ONPCSB) au poste de directrice des risques et des affaires réglementaires » Tradesilvania.com nombra a Mihaela Drăgoiu nueva directora de Riesgos y Asuntos Regulatorios